LB Pharmaceuticals, Inc. (LBRX)
42.47
+0.33
(+0.78%)
USD |
NASDAQ |
Sep 18, 16:00
42.37
-0.10
(-0.24%)
After-Hours: 20:00
LB Pharmaceuticals Cash from Investing (Quarterly) : 0.089M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.089M |
| March 31, 2026 | -0.032M |
| December 31, 2025 | -0.04M |
| September 30, 2025 | -44.84M |
| June 30, 2025 | 0.009M |
| March 31, 2025 | 4.98M |
| Date | Value |
|---|---|
| December 31, 2024 | 13.54M |
| September 30, 2024 | 28.87M |
| June 30, 2024 | 6.886M |
| March 31, 2024 | -26.06M |
| March 31, 2023 | -9.799M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Ligand Pharmaceuticals, Inc. | 321.12M |
| Neumora Therapeutics, Inc. | 0.00 |
| ANI Pharmaceuticals, Inc. | -3.054M |
| Corcept Therapeutics, Inc. | -29.24M |
| Veru, Inc. | 1.802M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -37.63M |
| Cash from Financing (Quarterly) | -0.019M |
| Free Cash Flow | -82.83M |
| Free Cash Flow Per Share (Quarterly) | -1.261 |
| Free Cash Flow to Equity (Quarterly) | -39.74M |
| Free Cash Flow to Firm (Quarterly) | -37.99M |
| Free Cash Flow Yield | -7.16% |